Ikarian Capital, LLC Celcuity Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 39,900 shares of CELC stock, worth $416,556. This represents 0.06% of its overall portfolio holdings.
Number of Shares
39,900Holding current value
$416,556% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CELC
# of Institutions
98Shares Held
30.6MCall Options Held
16.2KPut Options Held
51.9K-
Baker Bros. Advisors LP New York, NY4.26MShares$44.5 Million0.51% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$36.2 Million1.54% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$26.9 Million2.15% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$24.7 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$17.5 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $156M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...